Given that GBP2 could mediate STAT1 signaling in both colorectal cancer and renal cell carcinoma [14, 49], we supposed that GBP2-STAT1 axis might be critical for regulating the tumor immune status in a variety of malignancies. This evidence concerns the gene STAT1 and renal cell carcinoma.